Humana Inc
UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says
Traders work at the post where UnitedHealth Group is traded on the floor of the New York Stock Exchange. Brendan McDermid | Reuters UnitedHealth Group‘s (UNH) quality quarterly results Friday are a good sign for the broader health-care landscape, CNBC’s Jim Cramer said. The managed-care giant earned an adjusted $6.56 per share on revenues of […]
Read More
Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings
It’s encouraging to see three Club stocks on the bullish side of Goldman Sachs’ new list of 25 tactical trades for earnings season. Asset allocation can be strategic or tactical. Strategic asset allocation generally refers to longer-term investing — think of this as your buy-and-hold approach. Tactical allocation, on the other hand, is more about […]
Read More
Monthly Meeting Q&A with Jim Cramer on everything from tech to health care to industrials
During the October Monthly Meeting , we took questions directly from Investing Club members. Here are Jim Cramer’s and portfolio director Jeff Marks’ responses. Their answers have been edited for clarity. 1. Why do rising interest rates have such a negative effect on technology stocks? (Rod) Jim Cramer: When the Federal Reserve started raising rates, […]
Read More
Here’s a rapid-fire update on all 36 stocks in our portfolio, including our latest addition
Jim Cramer ran through the names during the Club’s October Monthly Meeting on Wednesday. Source
Read More
15 stocks with a history of dividend growth are expected to deliver once again this year
Broadcom (AVGO), Caterpillar (CAT) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual dividend growth that Wall Street expects to continue in their current fiscal years. Long-term investors should look to own companies with a history of dividend growth instead of chasing stocks with high yields, Morgan Stanley strategists […]
Read More
Here are all the portfolio moves the Club made in this week’s oversold market
With the stock market deeply oversold this week, we put cash to work by picking stocks across a range of sectors including energy, technology and materials. We also added a former Club chipmaker to our Bullpen and upgraded a premium beer name to a buy rating. Finally, Friday’s market reversal helped us make good on […]
Read More
We’re booking some profits on this health insurance stock after waiting out its slump
It’s taken some patience. But shares of this company finally broke through $500 each in Friday trading, so we’re ringing the register. Source
Read More
These are the most oversold stocks throughout a harsh September for the marketplace
Wall Avenue is wrapping up a rough month. Nevertheless, some acquiring opportunities could be emerging. The S & P 500 is on pace to close September decrease by 4%, which would mark its worst month to month general performance of 2023. The Nasdaq and Dow Jones Industrial Normal are also headed for steep just one-month […]
Read More
Health care has had a tough year. Where we stand on our 5 stocks in the sector
There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the performance of the Club’s health-care holdings so far this year, in what’s been a challenging period for the industry overall. Of the 11 market sectors year to date, health care is the fourth worth-worst performer, falling 4%, followed by […]
Read More
Here’s a rapid-fire update on all 35 stocks in the Club’s portfolio, including a new buy
Jim Cramer ran through all 35 Club stocks during our September Monthly Meeting on Thursday. Source
Read More